Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript
Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.
Stay updated with breaking news from Nacho Abia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.
Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC.Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse.
/PRNewswire/ -- Olympus, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment...
Current leader Nacho Abia is leaving OCA at the end of this month to take over as CEO at Grifols, a Barcelona-based pharmaceutical company.
The change in leadership at the partnership -- an organization that promotes regional goals -- reflects how the local economy has become more global.